- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alivus Life Sciences Limited — Board Meeting, 06-11-2025: Outcome of Board Meeting
06-11-2025 | 06:47 pm
06-11-2025 | 06:47 pm
Alivus Life Sciences' board approved the financial results for the quarter and half-year ended Sept 30. Q2 revenue surged to ₹587.98 Cr & net profit to ₹130.03 Cr. H1 revenue hit ₹1189.83 Cr, with net profit at ₹251.56 Cr, showing solid growth.
No comments yet. Be the first to comment!